Perrigo to Buy Héra for $2.1 Billion, Furthering Nonprescription Focus

https://images.wsj.net/im-397524/medium


A Perrigo facility in Israel. Chief Executive Murray Kessler called the purchase of Héra ‘a trade for what was volatile and declining earnings to growing extremely high-quality earnings.’

Photo: amir cohen/Reuters

This post was originally published on Wall Street Journal

Financial News

Daily News on Investing, Personal Finance, Markets, and more!